Eckert & Ziegler Forms Strategic Partnership with Bicycle Therapeutics

Eckert & Ziegler SE, a key player in isotope technology, has announced a strategic partnership with Bicycle Therapeutics. This agreement focuses on the supply of radioisotopes and development of Bicycle Therapeutics' proprietary Bicycle® Radio Conjugates (BRC®). The partnership leverages Eckert & Ziegler's GMP facility in Berlin to ensure quality manufacturing for clinical trials.

Bicycle Therapeutics is renowned for its innovative bicyclic peptide technology, aimed at delivering precise therapeutic payloads. This collaboration seeks to address unmet medical needs by targeting areas previously inaccessible via conventional methods.

Executives from both companies express optimism, highlighting the synergy between Eckert & Ziegler's manufacturing proficiency and Bicycle Therapeutics' cutting-edge technology, aiming to advance the field of radiopharmaceuticals.